Videos & Podcasts
-
Phase 2 SNT-5505 interim myelofibrosis data read out webinar
-
Syntara CEO Talks JustStocks Video Through Positive Interim Data In Lead Myelofibrosis Trial
-
9News: World-first trial to understand link between violent dreams and Parkinson’s disease
-
Syntara CEO Gary Phillips Updates JustStocks Video On Blood Cancer Trial And Upcoming Catalysts
-
Syntara CEO Gary Phillips Speaks With JustStocks Video As Phase 2 Blood Cancer Trial Fully Recruits
-
Proactive interview: Syntara to start Phase 2 study targeting MDS
-
Proactive interview: Syntara raising $10 million to support for three phase 2 clinical trials
-
Proactive interview: Syntara doses first patient in phase 2 blood cancer study
-
Pharmaxis (ASX: PXS) Investor Briefing – Company Restructure
-
Investor briefing – phase 2 cancer clinical trial interim results
-
Investor briefing – phase 1c established scar clinical trial top line results
-
Pharmaxis to accelerate plans for myelofibrosis combination study after FDA talks